As the world advances in the digital era, it is no surprise that more and more consumers are turning to the internet for healthcare information, advice, and even medications. While online pharmacies have been around for decades, they...
Every day patients, payers, and providers must navigate the pharmaceutical industry to obtain and deliver treatment. Unfortunately, the industry is full of language and nuances that make this process unnecessarily difficult. When providers...
Last week, Kroger Health — the grocery store chain’s pharmacy business — surprised Express Scripts with written notice of intention to terminate their agreement for commercial...
On Monday, September 19, McKesson announced that it had signed an agreement with Rx Savings Solutions. This agreement focuses on the company’s plans to acquire Rx Savings Solutions to advance the...
A Pennsylvania Judge barred plaintiffs in an antitrust lawsuit from recouping substantial financial penalties in their case against a group of pharmaceutical companies. Judge Cynthia Rufe will not...
Pfizer Inc. and Biohaven Pharmaceutical announced that Pfizer will acquire Biohaven for $11.6 billion in cash after years of collaborative drug development, improving access to medicine used to treat...
Half of all Medicare Part D covered drugs and nearly half of all Medicare Part B covered drugs (48%) had price increases greater than inflation between July 2019 and July 2020, according to...
All Medicare plans must cover a wide range of prescription drugs, including most drugs in certain protected classes. But Medicare Part D plans must cover all or substantially all drugs in six...
Biogen recently announced that it will reduce the wholesale acquisition cost (WAC) of its Alzheimer’s disease treatment, Aduhelm, in the US by nearly 50 percent.
For a patient of average weight,...
PhRMA member companies encourage Congress to abandon old partisan ideas on drug pricing and pursue policies that address patients out of pocket costs, according to a new official letter.
The...
HHS Secretary Xavier Becerra recently released a comprehensive plan to lower prescription drug prices.
The Drug Pricing Plan, part of a broader initiative from Joe Biden’s Executive Order on...
GoodRx and Boehringer Ingelheim recently collaborated to increase affordable drug access for patients with type 2 diabetes or chronic obstructive pulmonary disease (COPD).
Under the...
In January 2020, prescription drug prices increased for 832 medications by an average of 4.6 percent, the largest increase that has occurred in years, according to a GoodRx analysis.
Of the...
The Pharmaceutical Research and Manufacturers of America (PhRMA) recently filed a complaint stating that the 340B Drug Pricing Program administrative dispute resolution (ADR) rule is “arbitrary...
A recent RAND Corporation report found that prescription drug prices in the US are significantly higher than in other nations, averaging 256 percent of those seen in 32 other countries.
Notably, the...
CMS has issued a final rule allowing payers to negotiate prescription drug pricing based on how well these drugs work for patients, a policy that could reduce overall healthcare spending and...
Even in a public health crisis, value-based drug pricing warrants consideration, according to arecent Health Affairs analysis reviewing alternative pricing options for COVID-19 treatment.
Daniel...
President Trump recently issued two regulations to lower prescription drug pricing through a slew of new initiatives at aim prescription drug spending in Medicare.
The reforms are the direct...
Insulin prices are more than eight times higher in the US than in 32 comparable, high-income nations combined, according to a new RAND Corporation study.
In the analysis, researchers used...
Prescription drugs were not covered for Medicare beneficiaries prior to 2006. But the passage of the Medicare Prescription Drug, Improvement, and Modernization Act developed Medicare Part D, a voluntary prescription benefit for Medicare...
